Scilex Holding Company
Scilex Holding Company (SCLX) Stock Ownership
Institutional vs insider vs public ownership from 13F and float data — top holders, activity, and insider trades below.
SEC 13F · FMP · SCLX · as of Sep 30, 2025
Ownership Breakdown
80
Institutional Holders
▲ 14 vs Q2
$14.97M
Total Inst. Value
▲ $11.24M vs Q2
8.49M
Shares Outstanding
freeFloat 82.44%
759,923
13F Shares Held
▲ 127,796 vs Q2
Institutional ownership = 13F shares ÷ total outstanding. Insider % = 100 − free float. Public % = free float − institution %. Data: FMP /symbol-positions-summary + /shares-float + SEC EDGAR.
Top Institutional Holders
SCLX largest shareholders · institutional ownership
Q3 2025 · SEC 13F
Showing top 10 holders
| Holder | Shares | % Owned | Weight | Value | Reported | Change |
|---|---|---|---|---|---|---|
VANGUARD GROUP INC biological products, (no diagnostic substances) | 282.4K | 2.44% | 2.44% | $5.56B | Nov 7, 2025 | ▼ 11.9K |
BLACKROCK, INC. biological products, (no diagnostic substances) | 98.4K | 84.85% | 84.85% | $1.94B | Nov 12, 2025 | ▼ 34.0K |
GEODE CAPITAL MANAGEMENT, LLC biological products, (no diagnostic substances) | 74.1K | 63.94% | 63.94% | $1.46B | Nov 12, 2025 | ▲ 12.3K |
ARMISTICE CAPITAL, LLC biological products, (no diagnostic substances) | 66.0K | 56.92% | 56.92% | $1.30B | Nov 17, 2025 | NEW |
STATE STREET CORP biological products, (no diagnostic substances) | 33.4K | 28.83% | 28.83% | $657.96M | Nov 14, 2025 | ▲ 21.5K |
HRT FINANCIAL LP biological products, (no diagnostic substances) | 31.9K | 27.52% | 27.52% | $627.00M | Nov 14, 2025 | NEW |
UBS GROUP AG biological products, (no diagnostic substances) | 25.6K | 22.12% | 22.12% | $504.79M | Nov 13, 2025 | ▲ 7.2K |
MORGAN STANLEY biological products, (no diagnostic substances) | 23.2K | 19.97% | 19.97% | $455.71M | May 27, 2026 | ▲ 5.1K |
RENAISSANCE TECHNOLOGIES LLC biological products, (no diagnostic substances) | 19.2K | 16.53% | 16.53% | $377.15M | Nov 13, 2025 | NEW |
ASHTON THOMAS PRIVATE WEALTH, LLC biological products, (no diagnostic substances) | 18.0K | 15.51% | 15.51% | $354.02M | Nov 4, 2025 | NEW |
Data from SEC Form 13F filings. Ownership bar normalised to largest holder. Change flags: isNew / isSoldOut / changeInSharesNumber (FMP extract-analytics/holder).
Institutional Activity
Q3 2025 vs prior quarter
Q3 2025
12
Increased
+61.1K shares15
New Positions
first time holders13
Decreased
−50.9K shares0
Sold Out
fully exitedNet shares change (top 50)
+10.1K
+61.1K / −50.9K
Net new holders
+14
15 new / 0 exited
Based on top 50 institutional holders by position size. Fields: isNew, isSoldOut, changeInSharesNumber (FMP extract-analytics/holder, limit=50).
Insider Buying vs Selling
SCLX insider trading · insider activity
Source: SEC Form 4
Insiders have been net buyers of shares recently. Selling may be driven by pre-scheduled Rule 10b5-1 plans rather than negative sentiment.
5
Buy transactions
3
Sell transactions
1.67
Buy/Sell ratio
$21M
Total disposed
Recent Insider Transactions
Showing 10 most recent · Common Stock only
| Name · Role | Date | Type | Shares | Price | Value | After Trans. | Filing |
|---|---|---|---|---|---|---|---|
Ma Stephen Hoi CFO, COO and Secretary | Apr 17, 2026 | Purchase | 650,000 | $1.20 | $780.0K | 650.0K | Form 4 ↗ |
Ji Henry Exec Chair, CEO and President | Apr 16, 2026 | Purchase | 3,250,000 | $1.20 | $3.90M | 3.25M | Form 4 ↗ |
Ji Henry Exec Chair, CEO and President | Apr 17, 2026 | Sale | 650,000 | $1.20 | $780.0K | 2.60M | Form 4 ↗ |
Scilex Holding Co 10 percent owner | Dec 26, 2025 | Sale | 3,689,016 | $0.75 | $2.77M | 261.41M | Form 4 ↗ |
Scilex Holding Co 10 percent owner | Dec 29, 2025 | Sale | 7,310,984 | $0.66 | $4.79M | 254.10M | Form 4 ↗ |
Scilex Holding Co 10 percent owner | Dec 30, 2025 | Sale | 9,657,300 | $0.54 | $5.21M | 244.45M | Form 4 ↗ |
Wu Yue Alexander director | Oct 8, 2025 | Award | 20,000 | $17.58 | $351.6K | 20.0K | Form 4 ↗ |
Ma Stephen Hoi CFO and COO | Oct 8, 2025 | Award | 60,000 | $17.58 | $1.05M | 60.0K | Form 4 ↗ |
Chun Jay director | Oct 8, 2025 | Award | 20,000 | $17.58 | $351.6K | 20.0K | Form 4 ↗ |
Ji Henry CEO and President | Oct 8, 2025 | Award | 120,000 | $17.58 | $2.11M | 120.0K | Form 4 ↗ |
Source: /insider-trading/search (FMP stable). Buy/Sell direction: acquisitionOrDisposition A=Buy, D=Sell. RSU vesting (M-Exempt) excluded from sentiment bar. All data from SEC EDGAR public filings.
About institutional & insider ownership
Scilex Holding Company (SCLX) is primarily owned by institutional investors, who hold approximately 8.9% of total shares outstanding. Company insiders own approximately 17.56%, while retail and public investors account for the remaining 73.49%.
The largest institutional shareholder of Scilex Holding Company is VANGUARD GROUP INC, holding approximately 282,424 shares — equal to 2.44% of outstanding shares — as of September 30, 2025.
A total of 80 institutional investors currently hold SCLX stock, with a combined institutional value of approximately $14,967,314 as of the most recent 13F filing period.
Frequently asked questions
SCLX ownershipScilex Holding Company (SCLX) is primarily owned by institutional investors, who hold approximately 8.9% of shares. The largest shareholder is VANGUARD GROUP INC with a 2.44% stake. Company insiders hold 17.56%. Data sourced from SEC Form 13F as of September 30, 2025.